Literature DB >> 6588493

Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.

S Szabo, G Pihan, G T Gallagher, A Brown.   

Abstract

Changes in gastric acid and pepsin secretions do not fully account for the duodenal ulcerogenic effect of cysteamine or propionitrile in the rat. We investigated the role of pancreatic and biliary secretions as well as motility changes in the duodenum. Bypass of bile to the jejunum and/or ablation of pancreatic secretion or drainage of these secretions through chronic duodenal fistula aggravated the cysteamine-induced duodenal ulcers. Biliary bypass to the proximal duodenum, on the other hand, decreased the incidence and intensity of experimental duodenal ulcers. An increased and dopamine-sensitive myoelectric activity caused by cysteamine or propionitrile was recorded in the proximal duodenum, indicating a state of hypermotility. Indeed, a decreased quantity of bilirubin was recovered through the chronic fistula in the proximal duodenum, suggesting an impaired delivery of bile to the ulcer area after cysteamine administration. Thus, duodenal hypermotility probably prevents the proper mix and neutralization of gastric acid and duodenal (mucosal, biliary and pancreatic) secretions, predisposing to ulceration in the proximal duodenum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6588493

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  9 in total

1.  MPTP, gastroduodenal motility, duodenal ulceration, and Parkinson's disease.

Authors:  S Szabo
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

2.  Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats.

Authors:  J C Mangla; G Pihan; H A Brown; S Rattan; S Szabo
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

3.  Effects of dopamine on gastric mucosal lesions induced by ethanol in rats. Possible involvement of antigastric motor activity mediated with alpha 2-adrenoceptors.

Authors:  K Takeuchi; H Nishiwaki; S Okabe
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

Review 4.  From peptic ulcer disease to NSAID gastropathy. An evolving nosology.

Authors:  S H Roth
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

5.  Effects of compound U74500A in animal models of gastric and duodenal ulceration.

Authors:  A Krantis; R K Harding; A E McKay; G P Morris
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

6.  Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats.

Authors:  K Takeuchi; H Nishiwaki; S Okabe
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

7.  Biliary and pancreatic secretions influence experimental duodenal ulcer without affecting gastric secretion in the rat.

Authors:  G Pihan; G T Gallagher; S Szabo
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

8.  Abnormalities in the duodenal transit and motility in duodenal ulcer patients: studies with a new isotopic technique.

Authors:  M G Quon; I Mena; J E Valenzuela
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

9.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.